Clopidogrel resistance caused by a failure to metabolize clopidogrel into its metabolites

被引：22

作者：

Heestermans, AACM

van Werkum, JW

Schömig, E

ten Berg, JM

Taubert, D

机构：

[1] St Antonius Hosp, Dept Cardiol, NL-3435 CM Nieuwegein, Netherlands

[2] Univ Cologne, Univ Hosp, Dept Pharmacol, Cologne, Germany

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2006年 / 4卷 / 05期

关键词：

D O I：

10.1111/j.1538-7836.2006.01891.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1143 / 1145

页数：3

共 10 条

[1] Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects [J].

Fontana, P ;

Dupont, A ;

Gandrille, S ;

Bachelot-Loza, C ;

Reny, JL ;

Aiach, M ;

Gaussem, P .

CIRCULATION, 2003, 108 (08) :989-995

[2] Clopidogrel for coronary stenting - Response variability, drug resistance, and the effect of pretreatment platelet reactivity [J].

Gurbel, PA ;

Bliden, KP ;

Hiatt, BL ;

O'Connor, CM .

CIRCULATION, 2003, 107 (23) :2908-2913

[3] Down-regulation of human CYP3A4 by the inflammatory signal interleukin 6:: molecular mechanism and transcription factors involved [J].

Jover, R ;

Bort, R ;

Gómez-Lechón, MJ ;

Castell, JV .

FASEB JOURNAL, 2002, 16 (11) :1799-+

[4] Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation - A new drug-drug interaction [J].

Lau, WC ;

Waskell, LA ;

Watkins, PB ;

Neer, CJ ;

Horowitz, K ;

Hopp, AS ;

Tait, AR ;

Carville, DGM ;

Guyer, KE ;

Bates, ER .

CIRCULATION, 2003, 107 (01) :32-37

[5] Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance [J].

Lau, WC ;

Gurbel, PA ;

Watkins, PB ;

Neer, CJ ;

Hopp, AS ;

Carville, DGM ;

Guyer, KE ;

Tait, AR ;

Bates, ER .

CIRCULATION, 2004, 109 (02) :166-171

[6]

Lee AJ, 2001, J PHARMACOL EXP THER, V298, P420

[7] Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction [J].

Matetzky, S ;

Shenkman, B ;

Guetta, V ;

Schechter, M ;

Bienart, R ;

Goldenberg, I ;

Novikov, I ;

Pres, H ;

Savion, N ;

Varon, D ;

Hod, H .

CIRCULATION, 2004, 109 (25) :3171-3175

[8] Identification and biological activity of the active metabolite of clopidogrel [J].

Savi, P ;

Pereillo, JM ;

Uzabiaga, MF ;

Combalbert, J ;

Picard, C ;

Maffrand, JP ;

Pascal, M ;

Herbert, JM .

THROMBOSIS AND HAEMOSTASIS, 2000, 84 (05) :891-896

[9] Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises [J].

Stentz, FB ;

Umpierrez, GE ;

Cuervo, R ;

Kitabchi, AE .

DIABETES, 2004, 53 (08) :2079-2086

[10] Pharmacokinetics of clopidogrel after administration of a high loading dose [J].

Taubert, D ;

Kastrati, A ;

Harlfinger, S ;

Gorchakova, O ;

Lazar, A ;

von Beckerath, N ;

Schömig, A ;

Schömig, E .

THROMBOSIS AND HAEMOSTASIS, 2004, 92 (02) :311-316

← 1 →